| ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
|---|---|---|---|---|---|---|
| CP004023 |
|
125317-39-7 |
Vinorelbine Ditartrate - 98.0~102.0% |
0 | C53H66N4O20 | |
| CP004459 |
|
59803-98-4 |
brimonidine - 99% |
0 | C11H10BRN5 | |
| CP006735 |
|
220127-57-1 |
Imatinib mesylate - 98.0%~102.0% |
0 | C30H35N7O4S | |
| CP003595 |
|
98769-84-7 |
Reboxetine mesylate - 99.0% |
0 | C19H23NO3.CH4O3S | |
| CP006536 |
|
127045-41-4 |
Pazufloxacin - 99% |
0 | C16H15N2O4F | |
| CP003523 |
|
161735-79-1 |
(R)-N-(Prop-2-yn-1-yl)-2,3-dihydro-1H-inden-1-amine methanesulfonate - 99% |
0 | C12H13N.CH4O3S | |
| CP002918 |
|
223652-90-2 |
Garenoxacin mesylate hydrate - 99% |
0 | C23H20N2O4F2.CH4O3S.H2O | |
| CP001391 |
|
56974-61-9 |
gabexate mesylate - 98.5% |
0 | C16H23N3O4.CH4O3S | |
| CP005543 |
|
7143-01-3 |
Methanesulfonic anhydride - 98% |
0 | C2H6O5S2 | |
| CP002048 |
|
555-29-3 |
DL-Methyldopa - 99% |
0 | C10H13NO4 | |
| CP000041 |
|
115956-12-2 |
Dolasteron - 98% |
0 | C19H20N2O3 | |
| CP000221 |
|
112811-71-9 |
1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid ethyl ester - ≥98.0％ |
0 | C16H15F2NO4 | |
| CP000082 |
|
477600-75-2 |
Tofacitinib - 99% |
0 | C16H20N6O | |
| CP007038 |
|
540737-29-9 |
Tofacitinib (Tasocitinib, CP-690550) - 99.61% |
0 | C16H20N6O.C6H8O7 | |
| CP006906 |
|
122111-01-7 |
((2R,3R)-3-(Benzoyloxy)-4,4-difluoro-5-oxotetrahydrofuran-2-yl)methyl benzoate - 99% |
0 | C19H14O6F2 | |
| CP001151 |
|
491-67-8 |
Baicalein - 98% |
0 | C15H10O5 | |
| CP007307 |
|
475207-59-1 |
Sorafenib tosylate - 98.0~102.0% |
0 | C28H24ClF3N4O6S | |
| CP007981 |
|
89250-26-0 |
2-(Chloromethyl)-4-(4-nitrophenyl)thiazole - 70% |
0 | C10H7N2O2SCL | |
| CP000326 |
|
1613220-15-7 |
Niraparib Tosylate - 98% |
0 | C26H30N4O5S | |
| CP002620 |
|
1514-85-8 |
2,2-difluoromalonic acid - 98% |
0 | C3H2F2O4 | |
